Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial (Q37135355)
Jump to navigation
Jump to search
scientific article published on December 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial |
scientific article published on December 2007 |
Statements
1 reference
Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial (English)
1 reference
S B Hanauer
1 reference
W J Sandborn
1 reference
C Dallaire
1 reference
A Archambault
1 reference
B Yacyshyn
1 reference
C Yeh
1 reference
N Smith-Hall
1 reference
1 reference
1 reference
Identifiers
1 reference